婦人科用機器の世界市場：2024年～2031年

概要

婦人科用機器の世界市場は、2023年に154億米ドルに達し、2031年には269億米ドルに達すると予測され、予測期間2024-2031年のCAGRは6.8%で成長します。

婦人科用機器は、女性の生殖器系に関連する状態を診断、治療、管理するために使用される医療用具および機器です。予防と治療の両方のアプローチをサポートし、妊産婦ケア、がん検診、不妊治療などさまざまな用途で使用されます。鏡やコルポスコープのような基本的な道具から、ロボット手術システムや超音波診断装置のような先端技術に至るまで、これらは女性の健康転帰と生活の質を向上させる。

市場力学：

促進要因と阻害要因

婦人科用機器の進歩

先進的な腹腔鏡ロボット手術は、子宮摘出、子宮筋腫摘出、子宮内膜症切除、骨盤臓器脱修復などの処置に婦人科で使用されています。その精度の高さにより、周囲の組織や臓器を傷つけるリスクが減り、合併症が少なくなります。切開創が小さいため、術後の痛み、入院期間、回復時間が短縮されます。視認性と操作性が向上したことで、子宮内膜移植や子宮筋腫を除去する外科医の能力が向上し、手術の成功率が高まる。

例えば、2024年4月、フランスの大手民間病院グループであるELSANの一部であるFranche-Comte Polyclinicと、協働ロボットのパイオニアであるフランス系アメリカ人のMoon Surgicalは、Maestroシステムが婦人科腹腔鏡手術に臨床使用されていることを発表しました。

厳しい規制要件

世界の婦人科用機器市場は、厳しい規制要件、高コスト、熟練ヘルスケア専門家の不足、文化的・社会的スティグマ、合併症やリスクなどの課題に直面しています。これらの要因は、特に低所得地域における市場の成長を妨げ、高度な婦人科手術へのアクセスを制限する可能性があります。さらに、文化的・社会的な偏見が認知や利用の障壁となり、合併症やリスクが患者やヘルスケア提供者の消極性につながることもあります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 婦人科用機器の進歩
    • 婦人科疾患の有病率の上昇
  • 抑制要因
    • 厳しい規制要件
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• 特許分析
• PESTLE分析
• SWOT分析
• DMIオピニオン

第6章 製品タイプ別

• 診断機器
• 外科用機器
• モニタリング機器

第7章 用途別

• 産科
• 婦人科
• 不妊治療
• その他

第8章 エンドユーザー別

• 病院
• クリニック
• 診断研究所
• その他

第9章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• 中東・アフリカ

第10章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第11章 企業プロファイル

• B. Braun Melsungen AG
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Medtronic Plc
• Cooper Surgical, Inc
• Richard Wolf GmbH
• Hologic, Inc
• Boston Scientific Corporation
• Stryker Corporation
• Karl Storz GmbH & Co. KG
• Ethicon, Inc
• MedGyn Products

第12章 付録

Overview

Global Gynecological Devices Market reached US$ 15.4 billion in 2023 and is expected to reach US$ 26.9 billion by 2031, growing at a CAGR of 6.8% during the forecast period 2024-2031

Gynecological devices are medical tools and equipment used to diagnose, treat, and manage conditions related to the female reproductive system. They support both preventive and therapeutic approaches, and are used in various applications such as prenatal care, cancer screening, and infertility treatments. From basic tools like speculums and colposcopes to advanced technologies like robotic surgical systems and ultrasound machines, they enhance women's health outcomes and quality of life.

Market Dynamics: Drivers & Restraints

Advancements in the gynecological devices

Advanced laparoscopic robotic surgery is used in gynaecology for procedures like hysterectomies, myomectomies, endometriosis resection, and pelvic organ prolapse repairs. Its precision reduces the risk of damage to surrounding tissues and organs, resulting in fewer complications. Smaller incisions reduce postoperative pain, hospital stays, and recovery times. The enhanced visualisation and maneuverability improve the surgeon's ability to remove endometrial implants and fibroids, increasing procedure success rates.

For instance, in April 2024, the Franche-Comte Polyclinic, part of ELSAN, the leading private hospital group in France, and Moon Surgical, a French-American pioneer in collaborative robotics, announced that the Maestro System is now being used clinically in gynecological laparoscopic procedures.

Stringent regulatory requirements

The global gynecological devices market faces challenges such as stringent regulatory requirements, high costs, shortage of skilled healthcare professionals, cultural and social stigmas, and complications and risks. These factors can hinder the growth of the market, especially in low-income regions, and limit access to advanced gynecological procedures. Additionally, cultural and social stigmas can create barriers to awareness and usage, and complications and risks may lead to reluctance among patients and healthcare providers.

Segment Analysis

The global gynecological devices market is segmented based on product type, application, end user and region.

The diagnostic devices from the product type segment accounted for approximately 41.3% of the gynecological devices market share

The diagnostic devices from the product type segment accounted for approximately 41.3%. Diagnostic devices, such as ultrasound systems, colposcopes, hysteroscopes, and mammography machines, are vital in the global gynecological devices market for early detection, diagnosis, and monitoring of various conditions like cervical cancer, ovarian cysts, endometriosis, and other reproductive health disorders. Advancements in imaging technologies have improved the accuracy and efficiency of these diagnostic tools, leading to better patient outcomes and promoting preventive care and treatment planning.

For instance, in Septembe 2024, Samsung Medison, a global medical equipment company, will showcase its HERA Z20 ultrasound system at the 34th annual ISUOG World Congress 2024 in Budapest. The premium ultrasound system, which is considered the most important in the field of OB&GYN ultrasound, features advanced AI diagnostic assistance features to improve women's and fetuses' health. The Live ViewAssist feature provides real-time diagnosis location, reduces measurement time, and increases accuracy by automatically classifying cross sections and providing measurement results for the entire quarter of OB&GYN.

Geographical Analysis

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to novel product launches, FDA approvals, presence of a well-established healthcare infrastructure, rising levels of awareness regarding the availability of diagnostic tests & treatments, and developed reimbursement coverage.

For instance, in September 2022, Olympus, a global technology leader in designing and delivering innovative solutions for medical and surgical procedures, announced the market launch of the Guardenia Contained Extraction System. Guardenia is the latest innovation in their contained tissue extraction product portfolio for gynecological procedures and is manufactured by Advanced Surgical Concepts (ASC) Ltd. of Bray, Ireland.

Market Segmentation

By Product Type

• Diagnostic Devices
• Surgical Devices
• Monitoring Devices

By Application

• Obstetrics
• Gynecology
• Fertility
• Others

By End User

• Hospitals
• Clinics
• Diagnostic Laboratories
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include B. Braun Melsungen AG, Medtronic Plc, Cooper Surgical, Inc, Richard Wolf GmbH, Hologic, Inc, Boston Scientific Corporation, Stryker Corporation, Karl Storz GmbH & Co. KG, Ethicon, Inc, MedGyn Products among others.

Key Developments

• In April 2024, GE HealthCare announced that it launched the Voluson Signature 20 and 18 ultrasound systems for women's health imaging applications. Chicago-based GE HealthCare designed the systems to integrate AI, advanced tools and an ergonomic design. They speed exam time for clinicians while delivering a clearer picture of various conditions impacting women's health. The latest systems combine high-performance hardware with flexible, scalable software to help increase confidence in diagnostic and treatment decisions.

Why Purchase the Report?

• To visualize the global gynecological devices market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the gynecological devices market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global gynecological devices market report would provide approximately 64 tables, 61 figures, and 186 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Advancements in the gynecological devices
    • 4.1.1.2. Rise in the prevalence of gynecological diseases
  • 4.1.2. Restraints
    • 4.1.2.1. Stringent regulatory requirements
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Patent Analysis
• 5.6. PESTLE Analysis
• 5.7. SWOT Analysis
• 5.8. DMI Opinion

6. By Product Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 6.1.2. Market Attractiveness Index, By Product Type
• 6.2. Diagnostic Devices*
  • 6.2.1. Introduction
• 6.3. Surgical Devices
• 6.4. Monitoring Devices

7. By Application

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
• 7.2. Market Attractiveness Index, By Application
• 7.3. Obstetrics*
  • 7.3.1. Introduction
  • 7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.4. Gynecology
• 7.5. Fertility
• 7.6. Others

8. By End User

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 8.1.2. Market Attractiveness Index, By End User
• 8.2. Hospitals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Clinics
• 8.4. Diagnostic Laboratories
• 8.5. Others

9. By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.6.1. U.S.
    • 9.2.6.2. Canada
    • 9.2.6.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.6.1. Germany
    • 9.3.6.2. UK
    • 9.3.6.3. France
    • 9.3.6.4. Italy
    • 9.3.6.5. Spain
    • 9.3.6.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.6.1. Brazil
    • 9.4.6.2. Argentina
    • 9.4.6.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.6.1. China
    • 9.5.6.2. India
    • 9.5.6.3. Japan
    • 9.5.6.4. South Korea
    • 9.5.6.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

• 11.1. B. Braun Melsungen AG*
  • 11.1.1. Company Overview
  • 11.1.2. Product Portfolio and Description
  • 11.1.3. Financial Overview
  • 11.1.4. Key Developments
• 11.2. Medtronic Plc
• 11.3. Cooper Surgical, Inc
• 11.4. Richard Wolf GmbH
• 11.5. Hologic, Inc
• 11.6. Boston Scientific Corporation
• 11.7. Stryker Corporation
• 11.8. Karl Storz GmbH & Co. KG
• 11.9. Ethicon, Inc
• 11.10. MedGyn Products

LIST NOT EXHAUSTIVE

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us